Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 7,777-7,788 of 10,592
Other study type icon
CompletedNCT03985163

Patient Reported Outcomes for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionOtherOver 18 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Behavioral study icon
WithdrawnNCT03244852

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In United States
OCDOtherFrom 21 Years to 64 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
OCD
Drug study icon
CompletedNCT06391593

PD, PK, and Safety of ALTO-203 in people with MDD

This study exists to learn from real-world information that can show how the medication ALTO-203 fits into care. Researchers are trying to understand whether the medication ALTO-203 can improve attention, thinking, or day-to-day functioning.

In United States
DepressionDrugA study involving a medication or substance.From 25 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Drug study icon
CompletedNCT05202327

PDC-1421 Treatment in adults with ADHD

This study exists to compare options and see whether the medication PDC-1421 offers something meaningfully different. Researchers are trying to understand whether the medication PDC-1421 can give earlier or clearer feedback during care.

In United States
ADHDDrugFrom 18 Years to 70 Years
Countries
United States, Taiwan
Sponsor
BioLite, Inc.
Condition
ADHD
Drug study icon
CompletedNCT01435928

PEARL Schizophrenia Maintenance

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, France, Italy, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.